Author

R. Detroja

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Organism:human· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

M. Frenkel-Morgenstern· 2 shared A. Gorohovski· 1 shared C. Flueh· 1 shared D. Raviv Shay· 1 shared H. Moore· 1 shared I. Masuda· 1 shared M. Kurtz· 1 shared R. Glass· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

M. Frenkel-Morgenstern

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

tRNA Methylation Resolves Codon Usage Bias at the Limit of Cell Viability

I. Masuda, Y. Yamaki, R. Detroja, S. Tagore, H. Moore, S. Maharjan, Y. Nakano, T. Christian, R. Matsubara, T. M. Lowe, M. Frenkel-Morgenstern, Y.-M. Hou

This study shows that m1G37 tRNA modification neutralizes differential proline codon decoding, and its absence requires a minor isoacceptor for E. coli viability.

bioRxiv · May 14, 2022Microbiology

A liquid biopsy platform for detecting gene-gene fusions as glioma diagnostic biomarkers and drug targets

V. Palande, R. Detroja, A. Gorohovski, R. Glass, C. Flueh, M. Kurtz, S. Perez, D. Raviv Shay, T. Siegal, M. Frenkel-Morgenstern

This study identifies gene-gene fusions in glioma patients using cfDNA from plasma, showing potential as diagnostic biomarkers and drug targets for precision medicine.

bioRxiv · Feb 25, 2020 · PreprintCancer Biology